Arsanis.com Website Review

addressing critical infectious disease threats with targeted monoclonal antibody immunotherapies. our current monoclonal antibody programs address specific bacterial and viral pathogens. monoclonal antibodies (mabs) have the potential. to create new ways of preventing and treating serious infections to improve individual outcomes and address the threat of antibiotic. resistance. our expertise lies in applying our de*p understanding of infectious disease pathogenesis paired with our ability to access some. of the most advanced mab discovery techniques and platforms available today. we have used this expertise to discover and develop novel mabs. with multiple mechanisms of action and high potency against their intended targets. sign up to get arsanis news and updates delivered to your inbox. example: yes, i would like to receive emails from arsanis. (you can unsubscribe anytime) ------------------------- by submitting this form, you are consenting to receive marketing emails from:. you can revoke your consent to receive emails at any time by using the safeunsubscribe® link, found at the bottom of every by signing up for email updates, you are granting: arsanis permission to email you. you may unsubscribe via the link found at the bottom of